Rowland Carmichael Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$349K Buy
16,020
+2,160
+16% +$42.1K 0.11% 196
2020
Q3
$244K Buy
13,860
+1,210
+10% +$22.5K 0.1% 237
2020
Q2
$238K Buy
+12,650
New +$224K 0.1% 232
2018
Q4
Sell
-34,574
Closed -$515K 342
2018
Q3
$515K Hold
34,574
0.2% 132
2018
Q2
$485K Buy
34,574
+5,820
+20% +$77.1K 0.21% 130
2018
Q1
$374K Sell
28,754
-203
-0.7% -$2.6K 0.2% 150
2017
Q4
$399K Buy
+28,957
New +$391K 0.21% 144
2017
Q3
Sell
-12,982
Closed -$167K 302
2017
Q2
$167K Buy
12,982
+1,000
+8% +$13.3K 0.1% 230
2017
Q1
$154K Buy
+11,982
New +$153K 0.09% 226

Other funds holding MPT

Rowland Carmichael Advisors's MPT Position: Q4 2020 in Review

Rowland Carmichael Advisors increased its Medical Properties Trust (MPT) stake by 16% in Q4 2020, buying an estimated $42.1K and bringing the position to 16,020 shares worth $349K. The position accounts for 0.11% of the portfolio, ranked #196.

Rowland Carmichael Advisors first reported a position in MPT in Q1 2017 and has held it in 9 quarters since. The position peaked at $515K in Q3 2018. 537 funds tracked by Wall St. Rank hold MPT as of Q4 2020.

  • Rowland Carmichael Advisors held 16,020 shares of Medical Properties Trust worth $349K as of Q4 2020.
  • Rowland Carmichael Advisors bought 2,160 Medical Properties Trust shares in Q4 2020, an estimated $42.1K.
  • Medical Properties Trust made up 0.11% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #196 holding.
  • Rowland Carmichael Advisors first reported a position in Medical Properties Trust in Q1 2017 and has held it in 9 quarters since.
  • Rowland Carmichael Advisors's Medical Properties Trust position peaked at $515K in Q3 2018.
  • 537 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.